Ignite Creation Date:
2025-12-24 @ 11:43 PM
Ignite Modification Date:
2025-12-25 @ 9:35 PM
Study NCT ID:
NCT03575351
Status:
COMPLETED
Last Update Posted:
2025-08-03
First Post:
2018-06-14
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Study to Compare the Efficacy and Safety of JCAR017 to Standard of Care in Adult Subjects With High-risk, Transplant-eligible Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphomas
Sponsor:
Celgene
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-10-23
Start Date Type:
ACTUAL
Primary Completion Date:
2023-10-23
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-10-23
Completion Date Type:
ACTUAL
First Submit Date:
2018-06-14
First Submit QC Date:
None
Study First Post Date:
2018-07-02
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-10-23
Results First Submit QC Date:
None
Results First Post Date:
2025-08-03
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-07-15
Last Update Post Date:
2025-08-03
Last Update Post Date Type:
ACTUAL